Doxazosin mesylate side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Doxazosin mesylate. Common side effects include renal failure acute among females and drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 10,059 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,059 people who take Doxazosin Mesylate and have side effects are studied.
What is Doxazosin Mesylate?
Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. eHealthMe is studying from 10,059 Doxazosin mesylate users for its effectiveness, alternative drugs and more.
Number of Doxazosin mesylate reports submitted per year:
Doxazosin mesylate side effects by time on the drug *:
Doxazosin mesylate side effects by gender *:
Doxazosin mesylate side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Doxazosin mesylate?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on doxazosin mesylate (the active ingredients of Doxazosin mesylate) and Doxazosin mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Doxazosin mesylate:
- Doxazosin mesylate (10,059 reports)
Common Doxazosin mesylate side effects:
All Doxazosin mesylate side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fentanyl and Extradural Haematoma - 2 seconds ago
- Cetirizine Hydrochloride and Osteosclerosis - 2 seconds ago
- Flagyl and Breast Cancer Recurrent - 4 seconds ago
- Sotalol Hydrochloride and Eye Disorder - 6 seconds ago
- Mometasone Furoate and Movement - Uncontrolled Or Slow - 14 seconds ago